Title Category Credit Event date Costsort descending
Psychosocial Considerations in Post-Hematopoietic Stem Cell Transplantation
  • Behavioral health
  • Disease Management
  • Oncology
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • CDR - Dietitians
  • ASWB - Social Workers
$0.00 This activity will discuss the current approach for screening and management of these complications and will review data regarding the negative associations among psychological distress, health outcomes, successful HSCT, and increased mortality. Barriers in the delivery of psychosocial care and care models to address these issues will also be outlined.
Precision Medicine: Expanding Opportunities
  • Disease Management
  • Oncology
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • CDR - Dietitians
  • ASWB - Social Workers
$0.00 This activty will discuss how precision medicine is quickly becoming a standard of care in the field of oncology and will explore recent advances in such applications as gene sequencing, molecular diagnostic assays, liquid biopsies and biomarkers. Future applications and innovations in precision medicine tailored to the treatment of specific cancers will also be examined.
Selecting Appropriate Treatments Based on Geriatric and Fragility Assessments
  • Disease Management
  • Oncology
  • Older Adults
  • Transplantation
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • CDR - Dietitians
  • ASWB - Social Workers
$0.00 This activity will provide an overview of geriatric and frailty assessment tools that can assist in guiding cancer- and transplant-related decision making through the risk stratification of older individuals before therapy is initiated. Data surrounding the relationship among increased age, geriatric- and frailty-assessment results, and disease outcomes will also be explored. Key considerations in how to best incorporate these sometimes time-intensive assessments into practice will be outlined, along with discussion of how interprofessional collaboration among members of the health care team in the creation of care plans can facilitate quality care.
Social Determinants of Health in Cancer Care
  • Disease Management
  • Health Equity
  • Oncology
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • CDR - Dietitians
  • ASWB - Social Workers
$0.00 This activity will review the impact of poorer SDOH status on cancer care, disease progression, outcomes, access to treatment and many other aspects. It will also present care models, strategies and resources to help health care professionals best confront the challenges faced by many individuals with cancer.
A Closer Look at Novel Treatment Therapies for Acute Myeloid Leukemia
  • Disease Management
  • Oncology
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • CDR - Dietitians
  • ASWB - Social Workers
$0.00 This activity will discuss these novel agents’ indications, risks, and benefits and will address which patient populations are most likely to benefit from particular agents. In addition, early-phase clinical trials and emerging therapies will be explored.
Advances in Gene Therapy for Sickle Cell Disease and Thalassemia
  • Disease Management
  • Oncology
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • CDR - Dietitians
  • ASWB - Social Workers
$0.00 This session will examine the genetic approaches being explored for these diseases, such as the introduction of a corrected or modified β-globin gene and gene-sequence editing. It will also explore the genetic modalities utilized, such as genome-editing technologies including the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene-editing system and lentiviral vectors. The safety, efficacy and challenges associated with these therapies will also be outlined.
Emerging Applications of CAR T-cell Therapy in Cancer
  • Disease Management
  • Oncology
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • CDR - Dietitians
  • ASWB - Social Workers
$0.00 This activity will explore the most recent advances of this rapidly evolving therapy, including current data on its efficacy, limitations and challenges in the treatment of multiple myeloma and solid tumors. It will provide an overview of currently existing guidelines for CAR T-cell therapy and will describe best practices in determining individuals’ eligibility for this type of therapy, including factors that may affect treatment efficacy and outcomes.
Cervical Cancer: Etiology, Diagnosis, Treatment Options and Outcomes
  • Oncology
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • ASWB - Social Workers
$0.00 During this educational activity, learners will become familiar with the etiology and diagnosis of cervical cancer and explore treatment options and outcomes for relapsed, recurrent and metastatic disease. Advances in current cervical cancer clinical research trials will also be addressed.
Achieving Value-Based Care: The Role of Oncology Clinical Pathways
  • Oncology
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • Attendance - General Attendance
  • CCMC - General - Case Managers
$0.00 This activity will discuss best practices in cancer care, provide an overview of the current status of pathways in oncology and explore their role in helping practices to deliver value-based care.
Living-Donor Liver Transplant for Patients with Liver Cancer
  • Disease Management
  • Managed care
  • Oncology
  • Transplantation
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • ASWB - Social Workers
$0.00 This activity will provide an overview of the living-donor liver transplant procedure, the advantages and disadvantages of living-donor liver transplant, and the optimal timing for offering living donations to patients with liver cancer. Dr. Hughes will discuss the innovative approach advanced by experts at UPMC in which patients with liver cancer are offered the option of a living-donor transplant. He will discuss the experience and expertise offered by the UPMC Liver Transplant Program and their collaborative approach to working with referring physicians.